TABLE 2.
Model 1 | Model 2 | |||
β (95% CI) | p-value | β (95% CI) | p-value | |
Subjects n | 270 | 259 | ||
COPD CB+ | −35.2 (−57.9–−12.5) | 0.002 | −38.2 (−61.7–−14.6) | 0.002 |
Male COPD CB+ | −42.8 (−77.3–−8.2) | 0.016 | −42.8 (−78.1–−7.6) | 0.018 |
Female COPD CB+ | −29.4 (−58.7–−0.05) | 0.050 | −36.1 (−67.1–−5.2) | 0.022 |
Annual lung function decline (mL·year-1) was calculated by dividing the difference between two FEV1 measurements by the number of years between the two measurements. β-values represent the additional decline of FEV1 in chronic obstructive pulmonary disease (COPD) CB+ subjects compared to COPD subjects without chronic bronchitis. Model 1: age and sex# adjusted; model 2: adjusted for age, sex# and pack-years of cigarette smoking. #: unstratified analyses only.